Introducing ACUVUE® OASYS MAX 1-Day: The daily contact lens helping Australians to always be at their MAX

Johnson & Johnson*, a global leader in eye health, today announced the launch of its newest innovation in Australia ACUVUE® OASYS MAX 1-Day contact lenses and ACUVUE® OASYS MAX 1-Day MULTIFOCAL contact lenses, for wearers who want added comfort and clarity to support their lifestyle.

The lenses arrive at a pivotal time, as the demands on our eyes become ever greater. Between work and personal devices, adults spend an average of 13+ hours looking at screens daily[i], as the battle for our attention and the lure of the infinite scroll function become a well-known feature of our lives. The latest innovation from ACUVUE® has been designed with today’s modern lifestyles in mind. A fresh, dynamic solution for those who enjoy the freedom to live life outside their frames while maximizing their visual performance in all of life’s circumstances - at work, at play and in-between.

Through an unprecedented combination of new technologies, ACUVUE® OASYS MAX 1-Day lenses have been built for reliable comfort and performance, to overcome whatever the day brings. TearStable™ Technology maximizes tear-film stability and locks in moisture for exceptional all-day comfort2, while the OptiBlue™ light filter has the highest level blue-violet light filter in the industry at 60%‡,1 to help reduce light scatter and increase visual clarity, day and night. In addition, ACUVUE® OASYS MAX 1-Day lenses block 99.9% UVA rays and 100% UVB rays.††,§§,[ii],[iii]

As Australians continue to redefine what success and fulfillment means in this new digital intensive world, the ACUVUE® OASYS MAX 1-Day features provide the assurance that their lenses will keep up with them, giving them the freedom and flexibility to pursue their ambitions, side hustles, hobbies, and new experiences, whatever they may be.

“Through a deep innovation heritage in eyecare, Johnson & Johnson has seen how the needs of contact lens wearers have changed over time. In the age of digital technology and a persistent trend towards longer screen times, it is our role to continuously predict, adapt, and innovate to support our wearers’ needs,” said Michelle Ho, Business Unit Director, Vision, Johnson & Johnson, Australia and New Zealand. “There’s a huge need for innovation like ACUVUE® OASYS MAX 1-Day, that has been informed by wearers and eye care professionals, priming it to keep up with the lifestyles of all Australians, and address eye strain as a result of longer days and increased time looking at digital devices.”

For patients with presbyopia (a condition that happens to everyone around age 40 negatively impacting near vision, particularly in dim light), ACUVUE® OASYS MAX 1-Day MULTIFOCAL contact lenses provide crisp, clear vision at all distances and in all lighting conditions, as well as all-day comfort.[iv] The lenses combine the same two powerful technologies – TearStable™ Technology and the OptiBlue™ light filter – plus PUPIL OPTIMISED DESIGN technology, which tailors 100% of parameters to pupil size variations across both age and refraction compared to less than 2% for the leading competitor, for exceptionally effortless vision.§,3 This is the same technology that is available across all ACUVUE® Multifocal contact lenses.7

ACUVUE® OASYS MAX 1-Day builds on the ACUVUE® OASYS portfolio of products, which is unbeaten in comfort across 29 clinical studies.‡‡ In clinical trials of ACUVUE® OASYS MAX 1-Day, nearly 90% of wearers reported all-day comfort and a reduction in tired eyes from digital devices, and nearly 100% agreed the lenses provided clear, reliable vision.2

For more information and to stay informed of product availability, please visit https://au.jnjvisionpro.com/

The lenses will be available to wearers in Australia from 1 July 2024.